1 study found for:    NCT01387555
Show Display Options
Rank Status Study
1 Active, not recruiting A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   HCC
Interventions: Biological: JX-594 recombinant vaccina GM-CSF;   Other: Best Supportive Care

Indicates status has not been verified in more than two years